Global Immune System Allergy Treatment Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Immune System Allergy Treatment market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Immune System Allergy Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Immune System Allergy Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Immune System Allergy Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Immune System Allergy Treatment include Sanofi, Johnson and Johnson Services, Inc., Pfizer Inc., GlaxoSmithKline plc, Stallergenes Greer, LETIPharma, Dermapharm Holding, Allergy Therapeutics and Allergan plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immune System Allergy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune System Allergy Treatment.
The Immune System Allergy Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune System Allergy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Immune System Allergy Treatment Segment by Company
Sanofi
Johnson and Johnson Services, Inc.
Pfizer Inc.
GlaxoSmithKline plc
Stallergenes Greer
LETIPharma
Dermapharm Holding
Allergy Therapeutics
Allergan plc
ALK-Abelló A/S
Immune System Allergy Treatment Segment by Type
Allergy Injection
Sublingual Immunotherapy
Immune System Allergy Treatment Segment by Application
Hospital
Clinic
Others
Immune System Allergy Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Allergy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune System Allergy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Allergy Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Immune System Allergy Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
According to APO Research, The global Immune System Allergy Treatment market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Immune System Allergy Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Immune System Allergy Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Immune System Allergy Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Immune System Allergy Treatment include Sanofi, Johnson and Johnson Services, Inc., Pfizer Inc., GlaxoSmithKline plc, Stallergenes Greer, LETIPharma, Dermapharm Holding, Allergy Therapeutics and Allergan plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immune System Allergy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune System Allergy Treatment.
The Immune System Allergy Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune System Allergy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Immune System Allergy Treatment Segment by Company
Sanofi
Johnson and Johnson Services, Inc.
Pfizer Inc.
GlaxoSmithKline plc
Stallergenes Greer
LETIPharma
Dermapharm Holding
Allergy Therapeutics
Allergan plc
ALK-Abelló A/S
Immune System Allergy Treatment Segment by Type
Allergy Injection
Sublingual Immunotherapy
Immune System Allergy Treatment Segment by Application
Hospital
Clinic
Others
Immune System Allergy Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Allergy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune System Allergy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Allergy Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Immune System Allergy Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Table of Contents
100 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Immune System Allergy Treatment Market Size Overview by Region 2020 VS 2024 VS 2031
- 1.4 Global Immune System Allergy Treatment Market Size by Region (2020-2031)
- 1.4.1 Global Immune System Allergy Treatment Market Size by Region (2020-2025)
- 1.4.2 Global Immune System Allergy Treatment Market Size by Region (2026-2031)
- 1.5 Key Regions Immune System Allergy Treatment Market Size (2020-2031)
- 1.5.1 North America Immune System Allergy Treatment Market Size Growth Rate (2020-2031)
- 1.5.2 Europe Immune System Allergy Treatment Market Size Growth Rate (2020-2031)
- 1.5.3 Asia-Pacific Immune System Allergy Treatment Market Size Growth Rate (2020-2031)
- 1.5.4 South America Immune System Allergy Treatment Market Size Growth Rate (2020-2031)
- 1.5.5 Middle East & Africa Immune System Allergy Treatment Market Size Growth Rate (2020-2031)
- 2 Immune System Allergy Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Allergy Injection
- 2.1.2 Sublingual Immunotherapy
- 2.2 Global Immune System Allergy Treatment Market Size by Type
- 2.2.1 Global Immune System Allergy Treatment Market Size Overview by Type (2020-2031)
- 2.2.2 Global Immune System Allergy Treatment Historic Market Size Review by Type (2020-2025)
- 2.2.3 Global Immune System Allergy Treatment Market Size Forecasted by Type (2026-2031)
- 2.3 Global Immune System Allergy Treatment Market Size by Regions
- 2.3.1 North America Immune System Allergy Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.2 Europe Immune System Allergy Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.3 Asia-Pacific Immune System Allergy Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.4 South America Immune System Allergy Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.5 Middle East and Africa Immune System Allergy Treatment Market Size Breakdown by Type (2020-2025)
- 3 Immune System Allergy Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Others
- 3.2 Global Immune System Allergy Treatment Market Size by Application
- 3.2.1 Global Immune System Allergy Treatment Market Size Overview by Application (2020-2031)
- 3.2.2 Global Immune System Allergy Treatment Historic Market Size Review by Application (2020-2025)
- 3.2.3 Global Immune System Allergy Treatment Market Size Forecasted by Application (2026-2031)
- 3.3 Global Immune System Allergy Treatment Market Size by Regions
- 3.3.1 North America Immune System Allergy Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.2 Europe Immune System Allergy Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.3 Asia-Pacific Immune System Allergy Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.4 South America Immune System Allergy Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.5 Middle East and Africa Immune System Allergy Treatment Market Size Breakdown by Application (2020-2025)
- 4 Global Market Dynamics
- 4.1 Immune System Allergy Treatment Industry Trends
- 4.2 Immune System Allergy Treatment Industry Drivers
- 4.3 Immune System Allergy Treatment Industry Opportunities and Challenges
- 4.4 Immune System Allergy Treatment Industry Restraints
- 5 Competitive Insights by Company
- 5.1 Global Top Players by Immune System Allergy Treatment Revenue (2020-2025)
- 5.2 Global Immune System Allergy Treatment Industry Company Ranking, 2023 VS 2024 VS 2025
- 5.3 Global Immune System Allergy Treatment Key Company Headquarters & Area Served
- 5.4 Global Immune System Allergy Treatment Company, Product Type & Application
- 5.5 Global Immune System Allergy Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Immune System Allergy Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Immune System Allergy Treatment Players Market Share by Revenue in 2024
- 5.6.3 2024 Immune System Allergy Treatment Tier 1, Tier 2, and Tier 3
- 6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Comapny Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.1.4 Sanofi Immune System Allergy Treatment Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Johnson and Johnson Services, Inc.
- 6.2.1 Johnson and Johnson Services, Inc. Comapny Information
- 6.2.2 Johnson and Johnson Services, Inc. Business Overview
- 6.2.3 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.2.4 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio
- 6.2.5 Johnson and Johnson Services, Inc. Recent Developments
- 6.3 Pfizer Inc.
- 6.3.1 Pfizer Inc. Comapny Information
- 6.3.2 Pfizer Inc. Business Overview
- 6.3.3 Pfizer Inc. Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.3.4 Pfizer Inc. Immune System Allergy Treatment Product Portfolio
- 6.3.5 Pfizer Inc. Recent Developments
- 6.4 GlaxoSmithKline plc
- 6.4.1 GlaxoSmithKline plc Comapny Information
- 6.4.2 GlaxoSmithKline plc Business Overview
- 6.4.3 GlaxoSmithKline plc Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.4.4 GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio
- 6.4.5 GlaxoSmithKline plc Recent Developments
- 6.5 Stallergenes Greer
- 6.5.1 Stallergenes Greer Comapny Information
- 6.5.2 Stallergenes Greer Business Overview
- 6.5.3 Stallergenes Greer Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.5.4 Stallergenes Greer Immune System Allergy Treatment Product Portfolio
- 6.5.5 Stallergenes Greer Recent Developments
- 6.6 LETIPharma
- 6.6.1 LETIPharma Comapny Information
- 6.6.2 LETIPharma Business Overview
- 6.6.3 LETIPharma Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.6.4 LETIPharma Immune System Allergy Treatment Product Portfolio
- 6.6.5 LETIPharma Recent Developments
- 6.7 Dermapharm Holding
- 6.7.1 Dermapharm Holding Comapny Information
- 6.7.2 Dermapharm Holding Business Overview
- 6.7.3 Dermapharm Holding Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.7.4 Dermapharm Holding Immune System Allergy Treatment Product Portfolio
- 6.7.5 Dermapharm Holding Recent Developments
- 6.8 Allergy Therapeutics
- 6.8.1 Allergy Therapeutics Comapny Information
- 6.8.2 Allergy Therapeutics Business Overview
- 6.8.3 Allergy Therapeutics Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.8.4 Allergy Therapeutics Immune System Allergy Treatment Product Portfolio
- 6.8.5 Allergy Therapeutics Recent Developments
- 6.9 Allergan plc
- 6.9.1 Allergan plc Comapny Information
- 6.9.2 Allergan plc Business Overview
- 6.9.3 Allergan plc Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.9.4 Allergan plc Immune System Allergy Treatment Product Portfolio
- 6.9.5 Allergan plc Recent Developments
- 6.10 ALK-Abelló A/S
- 6.10.1 ALK-Abelló A/S Comapny Information
- 6.10.2 ALK-Abelló A/S Business Overview
- 6.10.3 ALK-Abelló A/S Immune System Allergy Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.10.4 ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio
- 6.10.5 ALK-Abelló A/S Recent Developments
- 7 North America
- 7.1 North America Immune System Allergy Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2 North America Immune System Allergy Treatment Market Size by Country (2020-2025)
- 7.3 North America Immune System Allergy Treatment Market Size Forecast by Country (2026-2031)
- 8 Europe
- 8.1 Europe Immune System Allergy Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2 Europe Immune System Allergy Treatment Market Size by Country (2020-2025)
- 8.3 Europe Immune System Allergy Treatment Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Immune System Allergy Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2 Asia-Pacific Immune System Allergy Treatment Market Size by Country (2020-2025)
- 9.3 Asia-Pacific Immune System Allergy Treatment Market Size Forecast by Country (2026-2031)
- 10 South America
- 10.1 South America Immune System Allergy Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2 South America Immune System Allergy Treatment Market Size by Country (2020-2025)
- 10.3 South America Immune System Allergy Treatment Market Size Forecast by Country (2026-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Immune System Allergy Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2 Middle East & Africa Immune System Allergy Treatment Market Size by Country (2020-2025)
- 11.3 Middle East & Africa Immune System Allergy Treatment Market Size Forecast by Country (2026-2031)
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
